MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

489863

Report Date :

08.02.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

RAJASTHAN ANTIBIOTICS LIMITED (w.e.f. 07.03.1989)

 

 

Formerly Known As :

CEPHAM MEDICAL LIMITED

 

CEPHAM MEDICAL LEASING LIMITED

 

 

Registered Office :

M 134, 2nd Floor, Connaught Place, Opposite Super Bazar, New Delhi - 110001

Tel. No.:

91-11-47666111

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

17.03.1986

 

 

Com. Reg. No.:

55-023616

 

 

Capital Investment / Paid-up Capital :

INR 52.758 Million

 

 

CIN No.:

[Company Identification No.]

U24231DL1986PLC023616

 

 

IEC No.:

0590000306

 

 

GSTIN :

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACR0925L 

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

The company is engaged in the business of manufacturing of sterile APIs. [Registered Activity]

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 1804000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1986 and it is engaged in manufacturing of sterile APIs.

 

As per the financial of March 2017, the company has registered growth of 62.51% in its revenue as compared to previous year’s revenue and has reported fair profit margin of 4.57% under review.

 

Rating takes into consideration the company’s established track record of business operations marked by sound net worth base along with comfortable debt coverage indicators and decent liquidity position.

 

Further, the company has reported earnings per share of INR 13.28 against its face value of INR 10.

 

However, rating is partially offset by its exposure to intense competition in the active pharmaceutical ingredient (API) industry, and exposure to risks related to licensing requirement and high degree of regulation in export markets.

 

Payments seem to be regular.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating = BBB

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

30.11.2017

 

 

Rating Agency Name

CRISIL

Rating

Short term rating = A3+

Rating Explanation

Moderate degree of safety and higher credit risk

Date

30.11.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 08.02.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Sanjeev Mittal

Designation :

Accounts Head

Contact No.:

91-11-47666111

Date :

07.02.2018

 

 

LOCATIONS

 

Registered Office :

M - 134, 2nd Floor, Connaught Place, Opposite Super Bazar, New Delhi – 110001, India

Tel. No.:

91-11-47666111

Fax No.:

91-11-43561743

E-Mail :

info@rallife.com

sales@rallife.com

Website :

http://www.rallife.com

 

 

Corporate Office :

M - 39, Connaught Circus, New Delhi – 110001, India

 

 

Factory :

Plot A - 619 and 630, RIICO Industrial Area, District Alwar, Bhiwadi – 301019, Rajasthan, India

Tel No.:

91-1493-222278/512378/512095

 


 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Ashish Pruthi

Designation :

Managing director

Address :

M - 255, Greater Kailash Part - II, Delhi - 110048, India

Date of Birth/Age :

19.08.1976

Date of Appointment :

01.04.2010

PAN No.:

AMIPP4490P

DIN No.:

01182469

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U52100DL2010PTC201633

REVIVAA BIOTECH PRIVATE LIMITED

16/04/2010

-

U24233DL2013PTC247115

VIVAAR EXIM PRIVATE LIMITED

07/01/2013

-

 

 

Name :

Mrs. Sushma Pruthi

Designation :

Director

Address :

M - 255, Greater Kailash, Delhi, - 110048, India

Date of Birth/Age :

09.09.1945

Date of Appointment :

22.06.2015

PAN No.:

AJDPP3632P

DIN No.:

00438457

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U45201DL1987PTC027884

D. P. TOWERS PRIVATE LIMITED

07/05/1987

-

U52300DL2009PTC189964

MANVIN HEALTH PRIVATE LIMITED

24/09/2014

-

U52602DL2009PTC192681

BARFANI BABA PHARMA PRIVATE LIMITED

24/09/2014

-

U52100DL2009PTC194061

ARVIV LIFESCIENCES PRIVATE LIMITED

24/09/2014

-

U24232DL2012PTC242545

VINMAN HEALTH PRIVATE LIMITED

24/09/2014

-

U24232DL2011PTC229519

STERINO EXIM PRIVATE LIMITED

30/12/2011

-

U15100DL2017PTC312632

DHANADEEPA PHARMA PRIVATE LIMITED

09/02/2017

-

 

 

Name :

Mr. Rakesh Kumar Girdhar

Designation :

Director

Address :

D 15/4, First Floor, Ardee City, Gurgaon - 122003, Haryana, India

Date of Birth/Age :

30.11.1962

Date of Appointment :

01.11.2008

PAN No.:

AHKPG4039N

DIN No.:

02380490

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U52100DL2009PTC194061

ARVIV LIFESCIENCES PRIVATE LIMITED

30/09/2015

-

U52100DL2010PTC201633

REVIVAA BIOTECH PRIVATE LIMITED

16/04/2010

-

 

 

KEY EXECUTIVES

 

Name :

Mr. Sanjeev Mittal

Designation :

Accounts Head

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

 

No. of Shares

Arviv Lifescience Private Limited, India

 

1344684

Ashish Pruthi

 

900

Radhika Pruthi

 

500

Manvia Heath Private Limited, India 

 

1343184

Barfani Baba Pharma Private Limited, India

 

2583397

Ashish Pruthi and Sons (HUF)

 

100

Meera Pruthi

 

3000

Total

 

5275765

 

 

AS ON 29.09.2017

 

Equity Share Break up

Percentage

Category

 

 

Promoters - Individual/Hindu Undivided Family – Indian

0.02

Promoters - Bodies corporate

99.91

Public/Other than promoters - Individual/Hindu Undivided Family – Indian

0.07

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in the business of manufacturing of sterile APIs. [Registered Activity]

 

 

Products / Services :

Item Code No. (ITC Code)

Product Description

29411090

Manufacture of pharmaceutical APIs

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

 

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Bank Name

State Bank of Bikaner and Jaipur

Branch

101-102, New Delhi House, 27, Barakhamba Road, New Delhi-110001, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

SECURED LOANS

31.03.2017

INR In Million

31.03.2016

INR In Million

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

83.188

34.276

(SBBJ Term Loan-61312916265 56625674 Allahabad Bank Term Loan-50268291399 Allahabad Bank Term Loan-II (A/c 50367633116)

 

 

Rupee term loans from others

0.000

0.376

Loans and advances from related parties

18.500

0.000

 

 

 

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

((A)Cash credit from banks 109767635

(B)Cash credit from banks 84850819

(C)Cash credit from banks 1239412))

207.016

0.000

Commercial paper

177.285

0.000

Other loans and advances

0.000

334.485

Total

485.989

369.137

 

 

Auditors :

 

Name :

J P Chawla and Company LLP

Chartered Accountants

Address :

43, Backlane Daryaganj, New Delhi-110002, India

PAN No.:

AAAFJ2213J

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Companies :

  • Arviv Lifesciences Private Limited, India

CIN No.: U52100DL2009PTC194061

 

  • Manvin Health Private Limited, India

CIN No.: U52300DL2009PTC189964

 

 

CAPITAL STRUCTURE

 

AS ON 29.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

INR 10/- each

INR 60.000 Million

600000

Preference Shares

INR 100/- each

INR 60.000 Million

 

Total

 

INR 120.000 Million

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5275765

Equity Shares

INR 10/- each

INR 52.758 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

52.758

52.758

52.758

(b) Reserves and Surplus

578.596

471.484

428.584

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

631.354

524.242

481.342

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

121.390

74.264

57.234

(b) Deferred tax liabilities (Net)

56.646

28.605

17.983

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

11.019

7.902

5.372

Total Non-current Liabilities (3)

189.055

110.771

80.589

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

384.301

334.485

184.810

(b) Trade payables

83.963

36.082

21.805

(c) Other current liabilities

61.014

44.123

61.674

(d) Short-term provisions

11.388

15.392

7.639

Total Current Liabilities (4)

540.666

430.082

275.928

 

 

 

 

TOTAL

1361.075

1065.095

837.859

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

463.471

238.475

266.598

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

0.000

1.907

70.988

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

14.911

8.968

18.307

(e) Other Non-current assets

134.714

139.276

53.137

Total Non-Current Assets

613.096

388.626

409.030

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

2.499

(b) Inventories

167.374

218.060

98.005

(c) Trade receivables

394.743

342.482

241.014

(d) Cash and bank balances

24.466

20.166

40.438

(e) Short-term loans and advances

105.109

60.510

46.873

(f) Other current assets

56.287

35.251

0.000

Total Current Assets

747.979

676.469

428.829

 

 

 

 

TOTAL

1361.075

1065.095

837.859

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

1534.356

944.135

1079.119

 

Other Income

31.788

140.185

72.262

 

TOTAL

1566.144

1084.320

1151.381

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1008.860

585.611

669.759

 

Purchases of Stock-in-Trade

0.000

16.688

18.396

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

41.357

(98.005)

9.124

 

Employee benefit expense

40.681

44.470

45.520

 

Expenditure on production, transportation and

Other expenditure pertaining to exploration

and production activities

171.857

0.000

0.000

 

Prior period items before tax

0.127

0.217

0.012

 

Other expenses

107.806

408.574

289.795

 

TOTAL

1370.688

957.555

1032.606

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

195.456

126.765

118.775

 

 

 

 

 

Less

FINANCIAL EXPENSES

50.586

40.574

35.490

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

144.870

86.191

83.285

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

13.816

18.963

16.867

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

131.054

67.228

66.418

 

 

 

 

 

Less

TAX

60.977

24.328

17.298

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

70.077

42.900

49.120

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

522.324

338.975

352.954

 

TOTAL EARNINGS

522.324

338.975

352.954

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

13.28

8.13

9.31

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

46.924

19.893

30.064

Net cash flows from (used in) operations

215.367

(94.904)

223.318

Net cash flows from (used in) operating activities

176.347

(100.732)

207.433

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365)

93.90

132.40

81.52

 

 

 

 

Account Receivables Turnover

(Income / Sunday Debtors)

3.89

2.76

4.48

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

30.38

21.87

11.57

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.17

0.58

1.21

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.42

0.53

0.35

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.52

0.49

0.43

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.88

0.82

0.57

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.86

0.82

0.57

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.73

0.46

0.70

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

3.86

3.12

3.35

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin [(PAT / Sales) * 100]

%

4.57

4.54

4.55

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

5.15

4.03

5.86

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

11.10

8.18

10.20

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.38

1.57

1.55

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.07

1.07

1.20

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.46

0.49

0.57

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

10.47

8.12

5.16

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.38

1.57

1.55

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

 

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

52.758

52.758

52.758

Reserves & Surplus

428.584

471.484

578.596

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

481.342

524.242

631.354

 

 

 

 

Long-term borrowings

57.234

74.264

121.390

Short term borrowings

184.810

334.485

384.301

Current maturities of long-term debts

30.064

19.893

46.924

Total borrowings

272.108

428.642

552.615

Debt/Equity ratio

0.565

0.818

0.875

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1079.119

944.135

1534.356

 

 

(12.509)

62.514

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1079.119

944.135

1534.356

Profit/ (Loss)

49.120

42.900

70.077

 

4.55%

4.54%

4.57%

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

COMPANIES BACKGROUND

 

The company is a limited company domiciled in India and incorporated under the provisions of the Companies Act, 1956. The company is engaged in Manufacturing of Bulk Drugs and Manufacturing cum trading of Herbal Products.

 

 

STATE OF COMPANY'S AFFAIR

 

The company is engaged in the business of manufacturing of sterile APIs. The highlights of the company's performance are as under:

 

During the year the Company has achieved revenue from operations of INR 1566.144 million as compared to the revenue of INR 1084.320 million in the immediately preceding financial year.

 

The Company has earned the net profit of INR 70.077 million after providing depreciation and tax as compared to the net profit of INR 42.900 million in the immediately preceding financial year.

 

UNSECURED LOANS:

 

PARTICULAR

31.03.2017

INR In Million

31.03.2016

INR In Million

Long-term Borrowings

 

 

Rupee term loans from others

19.702

0.000

Other loans and advances

0.000

39.612

Total

19.702

39.612

 

INDEX OF CHARGE:

 

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G28191500

100063530

Allahabad Bank

24/10/2016

-

-

20000000.0

Parliament Street Branch,17, Parliament Street, New Delhi-110001, India

2

G01531144

100019892

STATE BANK OF BIKANER & JAIPUR

23/03/2016

-

-

80000000.0

101-102, New Delhi House, 27, Barakhamba Road, New Delhi-110001, India

3

C44749190

10551487

Allahabad Bank

02/02/2015

-

-

58000000.0

Parliament Street Branch,17, Parliament Street, New Delhi-110001, India

4

C41378019

10544932

STATE BANK OF BIKANER & JAIPUR

31/12/2014

-

-

2000000.0

101-102, New Delhi House, 27, Barakhamba Road, New Delhi-110001, India

5

B70245279

10410254

State Bank of Bikaner & Jaipur

14/02/2013

-

-

1410000.0

16/67-68, Faiz Road, Karol Bagh, New Delhi-110005, India

6

B59481838

10379988

State Bank of Bikaner & Jaipur

13/09/2012

-

-

2242000.0

16/67-68, Faiz Road, Karol Bagh, New Delhi-110005, India

7

G39789367

10174483

State Bank of Bikaner and Jaipur

21/07/2009

27/03/2017

-

782500000.0

101-102, New Delhi House, 27, Barakhamba Road, New Delhi-110001, India

8

C13823406

10197763

STATE BANK OF BIKANER AND JAIPUR

04/01/2010

-

16/07/2014

1300000.0

16/67-68, Faiz Road, Karol Bagh, New Delhi-110005, India

9

B79882486

10288095

State Bank of Hyderabad

05/05/2011

-

20/07/2013

70000000.0

Flat No. 110, Suryakiran Building19 KG MargNew DelhiDL110001IN

10

A68344928

80023275

STATE BANK OF PATIALA

20/12/1990

-

20/08/2009

3900000.0

2nd Floor, Chandralok Building 36, Janpath, New Delhi-110001, India

 

FIXED ASSETS:

 

Tangible Asset:

  • Land
  • Building
  • Plant and equipment
  • Furniture and Fixture
  • Computer
  • Vehicles

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.14

UK Pound

1

INR 89.50

Euro

1

INR 79.43

 

 

INFORMATION DETAILS

 

Information Gathered by :

PON

 

 

Analysis Done by :

VIV

 

 

Report Prepared by :

BHG

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.